No Picture
Los Angeles Biotech Trending News

Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas

TUSTIN, Calif.: The new indications include Eyebrow lifts and lifting of Lax tissue of the Submental and Neck Areas 80% of patients participating in a multi-site clinical trial saw improvement in just 12 weeks TUSTIN, […]

No Picture
Los Angeles Biotech Trending News

NKGen Biotech Announces Positive SNK01 Clinical Trial Results Presented at the Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting

SANTA ANA, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — NKGen Biotech, a subsidiary of NKMax, harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today announced that […]

Los Angeles Biotech Trending News

UPDATE – Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced two oral […]

No Picture
Los Angeles Biotech Trending News

Hydrus Microstent Lowers Visual Field Loss by 47% According to New 5-Year Pivotal Trial Data

IRVINE, Calif.: IRVINE, Calif., Nov. 15, 2021 /PRNewswire/ — Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device intended to lower eye pressure for open-angle glaucoma patients, has announced […]

Los Angeles Biotech Trending News

Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)

LOS ANGELES, Nov. 13, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced two oral […]